and 1 other(s)
Aim: To describe Continuous Subcutaneous Insulin Infusion (CSII) settings in Type 1 Diabetes (T1D) patients with optimal glucose control. Methods: The study enrolled ninety-three CSII patients with T1D (age 12-25 years) that visited our center from January to December 2016. Patient characteristics were collected through the electronic medical record system and CSII characteristics were obtained from 8 weeks reports prior to Hba1c, generated by Carelink Therapy Management Software (Medtronic, Northridge, USA). Results: Patients were grouped according age: 12-18 years and 19-25 years. More than 70% of patients achieved HbA1c <7.5% (<58 mmol/mol). Significant difference in basal insulin was found between two age groups. Patients aged 12-18 years had five basal segments, less basal rate in early morning (03-07h) and slight decrease of afternoon basal rate (13-19h), comparing with patients aged 19-25 years with four basal segments, more basal rate in early morning (03-07h) and no decrease of afternoon basal rate (13-19h). Conclusion: Bolus wizard settings, frequent bolusing, multiple basal segments, and close follow up can be determinants for better control in T1D patients. Simple CSII settings as a tool, derived from our data may help clinicians to fine tune T1D patients and achieve optimal glucose control.
No datasets are available for this submission.
No license information is available for this submission.